e-learning
resources
Copenhagen 2005
Monday 19.09.2005
COPD: clinical physiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD)
A. Huertas, U. Testa, G. Mariani, R. Antonucci, E. Petrucci, G. Morici, M. Vignola, V. Bellia, P. Serra, M. R. Bonsignore, P. Palange (Rome, Palermo, Italy)
Source:
Annual Congress 2005 - COPD: clinical physiology
Session:
COPD: clinical physiology
Session type:
Thematic Poster Session
Number:
2346
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Huertas, U. Testa, G. Mariani, R. Antonucci, E. Petrucci, G. Morici, M. Vignola, V. Bellia, P. Serra, M. R. Bonsignore, P. Palange (Rome, Palermo, Italy). Low circulating CD34+ cells in chronic obstructive pulmonary disease (COPD). Eur Respir J 2005; 26: Suppl. 49, 2346
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
From pulmonary gas exchange to the interpretation of arterial blood gases
The physiology of breathlessness
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Decreased pulmonary immunoregulatory/suppressor (CD4+CD25+) T-lymphocytes in chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
Circulating auto antibodies in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2008 - Pathophysiology of COPD
Year: 2008
Airway T-lymphocytes expressing IFN-γ are reduced in smokers with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 6s
Year: 2002
Periostin levels in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Phenotype of T cells in lung tissue from smokers with or without chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 53s
Year: 2005
Analysis of peripheral blood lymphocytes in asthma and chronic obstructive pulmonary disease (COPD) patients
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Bronchial fibrocyte-like cells accumulate in chronic obstructive pulmonary disease (COPD) lungs.
Source: ERS Lung Science Conference 2018
Year: 2018
Subpopulation structure of lymphocytes in patients with chronic obstructive pulmonary disease (COPD) during exacerbation and after treatment
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Increased lung apoptosis and expression of ceramide in subjects with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Serum and skeletal muscle leptin in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Systemic effects of COPD
Year: 2005
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Circulating tumor cells in chronic obstructive pulmonary disease patients
Source: Annual Congress 2011 - Innovative diagnostic methods for lung cancer
Year: 2011
Determinants of peripheral blood neutrophils in advanced chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010
The state of patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 547s
Year: 2007
Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 89s
Year: 2002
Endothelial microparticles as markers of exercise capacity in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases
Year: 2018
Influence of bronchodilators on pulmonary hypertension (PH) in patients with moderate and severe chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005
Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018
Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept